Mercy BioAnalytics, Inc.
Diane Marcou has worked as a Consulting CFO in various biotech and healthcare companies, including Concerto Biosciences, Mercy BioAnalytics, Satellite Bio, STRM.BIO, Demark Financial, Boston Microfluidics, CoreMap, NFlection Therapeutics, Cytrellis Biosystems, and Immunome, Inc. Their work experience dates back to 2005, and they have held their most recent role at Concerto Biosciences since July 2022. Their roles in these companies have all been in the consulting capacity, and their tenure in each role has ranged from several months to several years.
From 1984 to 1988, Diane Marcou attended Boston College. During this time, they studied accounting but it is not known if they obtained a degree.
Mercy BioAnalytics, Inc.
Mercy BioAnalytics is a biotechnology company that aims to improve and save the lives of people through the early detection of cancer.It has developed a process that uses nano-particles that are extraordinarily abundant in blood and carry information about their parent cell – known as extracellular vesicles, or EVs – to detect stage I cancer.Paul Blavin and Joseph Sedlak founded the Natick, Massachusetts-based company in 2018.